Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
US12162950B2 · kind B2 · utility
0Cited by
160References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2022 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | May 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions and a method of inhibiting metastasis using anti-ROR1 antibodies or antigen binding fragments, ROR1 binding peptides and ROR1 vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.